|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
FY2021
12 months to Aug 31, 2021
|
FY2020
12 months to Aug 31, 2020
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Impairment of goodwill | |||||
| Equity earnings in Cencora | |||||
| Operating (loss) income | |||||
| Other income, net | |||||
| (Loss) earnings before interest and income tax provision (benefit) | |||||
| Interest expense, net | |||||
| (Loss) earnings before income tax provision (benefit) | |||||
| Income tax provision (benefit) | |||||
| Post-tax earnings from other equity method investments | |||||
| Net (loss) earnings from continuing operations | |||||
| Net earnings from discontinued operations | |||||
| Net earnings (loss) | |||||
| Net loss attributable to non-controlling interests | |||||
| Net earnings attributable to non-controlling interests - discontinued operations | |||||
| Net (loss) earnings attributable to Walgreens Boots Alliance, Inc. | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Net (loss) earnings per common share: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Total (in dollars per share) | |||||
| Earnings Per Share, Diluted | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Total (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...